19 July 2024
Latham & Watkins Advises Invetx in Acquisition by Dechra Pharmaceuticals
Advising firms
Deal team
22 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Kristen Grannis Lead | Latham & Watkins LLP | Partner | corporate | Boston |
| Spencer Ricks Lead | Latham & Watkins LLP | Partner | corporate | Boston |
| Gloria Ring Lead | Latham & Watkins LLP | Counsel | corporate | Boston |
| Andrew Rondeau | Latham & Watkins LLP | Associate | corporate | Not stated |
| Christine Kalpin | Latham & Watkins LLP | Associate | corporate | Not stated |
| Josh Friedman | Latham & Watkins LLP | Partner | benefits and compensation | Boston |
| Tessa Young | Latham & Watkins LLP | Associate | benefits and compensation | Not stated |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Dennis Poehland | Latham & Watkins LLP | Associate | tax | Not stated |
| Josh Holian | Latham & Watkins LLP | Partner | antitrust | Bay Area |
| Ian Conner | Latham & Watkins LLP | Partner | antitrust | Washington, D.C. |
| Patrick English | Latham & Watkins LLP | Partner | antitrust | Washington, D.C. |
| Ehson Kashfipour | Latham & Watkins LLP | Associate | antitrust | Not stated |
| Sarah Gagan | Latham & Watkins LLP | Partner | intellectual property | Boston |
| Eliot Choy | Latham & Watkins LLP | Counsel | intellectual property | New York |
| Arun Mohan | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy | Bay Area |
| Mitch Bennett | Latham & Watkins LLP | Associate | data privacy | Not stated |
| Elizabeth Richards | Latham & Watkins LLP | Partner | FDA regulatory | Washington, D.C. |
| Meryl Bartlett | Latham & Watkins LLP | Associate | FDA regulatory | Not stated |
| Eveline Van Keymeulen | Latham & Watkins LLP | Partner | EU regulatory | Brussels |
| Jeanne Fabre | Latham & Watkins LLP | Associate | EU regulatory | Not stated |
Stated terms
- Stated value
- USD 520m (US$520 million)
- What the figure measures
- Total transaction value
- Client
- Invetx, Inc.Sell-side
- Counterparties
- Dechra Pharmaceuticals Limited (Buy-side)